NCT06816849

Brief Summary

The aim of this study is to investigate the role of hydration and fluid intake in children and adolescents with primary headaches.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 27, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
Last Updated

February 10, 2025

Status Verified

March 1, 2023

Enrollment Period

8 months

First QC Date

January 27, 2025

Last Update Submit

February 3, 2025

Conditions

Keywords

primary headachepediatricchildrenhydrationwater intake

Outcome Measures

Primary Outcomes (3)

  • Headache frequency

    Number of headache episodes over last three months.

    4 months

  • Headache intensity

    Headache severity measured with the Visual Analog Scale (0 - 10).

    4 months

  • Headache duration

    Average length of headache episode measured in minutes.

    4 months

Secondary Outcomes (4)

  • Change in total body water

    4 months

  • Effect of nutritional advice on type of drink they have choosen

    4 months

  • Change in extracellular water

    4 months

  • Change in phase angle

    4 months

Study Arms (1)

Recommended fluid intake

EXPERIMENTAL

All participants received personalized consultation from a dietitian on adequate fluid intake and the selection of drinks based on dietary guidelines. They were required to follow the intervention for four months.

Other: Recommended water intake

Interventions

All participants received personalized consultation from a dietitian on adequate fluid intake and the selection of drinks based on dietary guidelines. They were required to follow the intervention for four months.

Recommended fluid intake

Eligibility Criteria

Age4 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 4-18 years.
  • Able to provide informed consent and willing to complete follow-up visits.
  • Primary headaches.
  • At least 1 headache per month.
  • Presence of headaches for at least 3 months or longer.

You may not qualify if:

  • Secondary headaches.
  • Without headaches for 3 months or more.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Centre Ljubljana

Ljubljana, 1000, Slovenia

Location

Related Publications (3)

  • Spigt MG, Kuijper EC, Schayck CP, Troost J, Knipschild PG, Linssen VM, Knottnerus JA. Increasing the daily water intake for the prophylactic treatment of headache: a pilot trial. Eur J Neurol. 2005 Sep;12(9):715-8. doi: 10.1111/j.1468-1331.2005.01081.x.

  • Spigt M, Weerkamp N, Troost J, van Schayck CP, Knottnerus JA. A randomized trial on the effects of regular water intake in patients with recurrent headaches. Fam Pract. 2012 Aug;29(4):370-5. doi: 10.1093/fampra/cmr112. Epub 2011 Nov 23.

  • Khorsha F, Mirzababaei A, Togha M, Mirzaei K. Association of drinking water and migraine headache severity. J Clin Neurosci. 2020 Jul;77:81-84. doi: 10.1016/j.jocn.2020.05.034. Epub 2020 May 20.

MeSH Terms

Conditions

Cluster Headache

Condition Hierarchy (Ancestors)

Trigeminal Autonomic CephalalgiasHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 27, 2025

First Posted

February 10, 2025

Study Start

March 1, 2023

Primary Completion

October 31, 2023

Study Completion

June 30, 2024

Last Updated

February 10, 2025

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations